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Abstract  
Background: Coping Cat, a generic cognitive-behavioural intervention for 
anxiety disorders in children and young people, is recommended in the UK for 
social anxiety disorder (SAD), generalised anxiety disorder (GAD), separation 
anxiety (SA), and specific phobias (SP), with disorder-specific approaches 
generally favoured in treatment of anxiety disorders in adults. 
Objectives: To compare Coping Cat with disorder-specific CBT interventions 
based on anxiety-related treatment outcomes.  
Study selection: Primary research articles describing treatment of children 
and young people aged 7-17 for SAD, GAD, SA, and SP, using Coping Cat or 
disorder-specific CBT.  
Results: Ten studies implemented Coping Cat and 4 implemented disorder-
specific CBT. One study compared Coping Cat with a disorder-specific 
approach. There was a lack of data to support use of Coping Cat in treatment 
of SPs. However, Coping Cat was equally effective as disorder-specific 
treatments for SA and SAD.  
Conclusions: A lack of data exists for disorder-specific CBT interventions 
compared to Coping Cat. 
 
Keywords 
Child and adolescent, anxiety disorder, disorder-specific, Coping Cat, 
Cognitive Behavioural Therapy 
 
  2 
Introduction 
Anxiety disorders are among the most common mental health disorders 
occurring in childhood (Cartwright-Hatton, McNicol, & Doubleday, 2006). In a 
UK study conducted in 1999 the estimated prevalence of anxiety disorders in 
children aged 5–15 years was 3.8%, accounting for around 40% of all DSM-IV 
disorders in this group (Ford, Goodman, & Meltzer, 2003). Moreover, high 
comorbidity has been reported in children and young people (CYP), both 
among different anxiety disorders and between anxiety disorders and other 
DSM-IV disorders such as depression (Ford et al., 2003; Kendall et al., 2010). 
It has been suggested that in the majority of cases of anxiety disorders 
diagnosed in adulthood the disorder may have begun in childhood or 
adolescence (Ferdinand & Verhulst, 1995; Kim-Cohen et al., 2003; Pine, 
Cohen, Gurley, Brook, & Ma, 1998). Accordingly, researchers have stressed 
the importance of early intervention for anxiety disorders in CYP (Kendall et 
al, 2004).  
The Children and Young People’s Improving Access to Psychological 
Therapies programme (CYP IAPT) was introduced in 2011 to improve existing 
Child and Adolescent Mental Health Services (CAMHS) in England. The CYP 
IAPT National Curriculum (2013) outlines recommended treatments for 
anxiety disorders. The Curriculum’s authors highlight a lack of NICE guidance 
on the treatment of generalised anxiety disorder (GAD), separation anxiety 
(SA) and social anxiety disorder (SAD) in CYP (p. 31, CYP IAPT 
Programme’s Education and Curriculum Task and Finish Group, 2013). 
According to the authors, the ‘most substantial’ evidence for a treatment 
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approach for the above disorders is for the Coping Cat (CC) programme. CC 
is also suggested as the treatment approach of choice for specific phobias 
(SP) in CYP. 
CC is a manualised cognitive-behavioural treatment for anxiety disorders 
developed by Kendall and colleagues (Kendall, 1994; Kendall et al., 1997; 
Kendall & Hedtke, 2006a; Kendall & Hedtke, 2006b). The treatment is 
recommended for children aged 7 to 13 years with GAD, SA, and/or SAD 
(Kendall, Hudson, Gosch, Flannery-Schroeder, & Suveg, 2008). A modified 
version of the treatment also exists for 14-17 year-olds. There are 16 hour-
long sessions in total, comprising 8 hours of ‘skills training’, and then 8 hours 
of ‘exposure tasks’, with the overall aim of equipping children with the skills to 
recognise and confront, rather than avoid, situations they find anxiety-
provoking. An important feature of CC is that it is not targeted toward a 
specific anxiety disorder presentation. The authors justify this ‘generalised’ 
approach on the grounds that there is a high degree of comorbidity between 
anxiety disorders in CYP (Creswell, Waite, & Cooper, 2014; Kendall et al., 
2010). In addition, well-validated maintenance models for specific anxiety 
disorders in CYP do not currently exist (Creswell et al., 2014).  
In contrast, in the cognitive-behavioural treatment of anxiety disorders in adult 
populations the use of disorder-specific approaches is commonplace and is 
supported by a strong evidence-base (e.g., Butler, Fennell, & Hackmann, 
2010; Kendall, 1994; Reynolds, Wilson, Austin, & Hooper, 2012; though see 
Schulte, Künzel, Pepping, & Schulte-Bahrenberg, 1992). For example, 
treatments for SP tend to focus largely on exposure to phobic stimuli and 
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often some cognitive restructuring; treatment for GAD tends to incorporate 
exposure to worry, relaxation training, cognitive restructuring and coping 
strategies, and treatment for SAD generally incorporates elements of 
exposure, cognitive restructuring, relaxation training, practice at reducing self-
monitoring behaviours, and social skills training (see Olatunji, Cisler, & 
Deacon, 2010 for a review). Therefore, while many treatments share similar 
elements, some are disorder-specific (e.g. social skills training in SAD, coping 
strategies in GAD). 
As Kendall (1994) noted, the evidence for disorder-specific versus ‘generic’ 
treatment approaches in CYP is lacking (see also Rapee, Schniering, & 
Hudson, 2009). Recently, knowledge has begun to advance in relation to this 
matter. For example, some studies have suggested poorer outcomes for 
generic CBT approaches for SAD in CYP compared to disorder-specific 
approaches (e.g., Creswell et al., 2014; Kerns, Read, Klugman, & Kendall, 
2013), although one study reported little advantage of a disorder-specific 
treatment approach compared to CC in the treatment of SA (Schneider et al., 
2013). Moreover, one recent study reported good outcomes for a single-
session treatment of SP (while the 16-session CC treatment is recommended 
by CYP IAPT; Ollendick et al., 2009). These findings highlight a need for 
systematic comparison of the efficacy of disorder-specific versus generic 
treatment approaches for anxiety disorders in CYP. 
A recent meta-analysis conducted by Reynolds et al. (2012) included a 
comparison of a number of ‘disorder-generic’ and ‘disorder-specific’ cognitive 
behavioural treatments for anxiety disorders in CYP. Reynolds et al. (2012) 
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reported that across  the 55 randomised controlled trials they included, the 
overall effect size was moderate for the treatment of anxiety disorders with 
disorder-generic approaches (including, but not limited-to, CC), whereas for 
disorder-specific treatments the effect size was medium-to-large. In their 
discussion, the authors concluded that disorder-specific treatment approaches 
appeared to have a larger effect size, but noted that a confounding variable 
was the lack of availability of separate treatment outcome data for different 
disorders, which was problematic for the calculation of effect sizes.  
An alternative approach to explore this important question further is the use of 
a critical, systematic, narrative review of the current literature. Specifically, the 
recommendations made by CYP IAPT’s National Curriculum appear to favour 
a disorder-generic treatment approach, CC, rather than disorder-specific 
approaches for the treatment of four different anxiety disorder presentations 
(GAD, SAD, SP and SA). The above-proposed alternative approach to the 
question of whether disorder-specific approaches are preferable to CC would 
allow for more flexible comparisons to be made for a relatively sparse 
literature, and could also highlight areas worthy of future research.  
Therefore, the aim of the present review was to undertake a critical, narrative 
review of whether disorder-specific cognitive behavioural interventions, as 
favoured in the treatment of anxiety disorders in adults, are more effective 
compared to the disorder-generic CC treatment approach for SAD, GAD, SA, 
or SP, in CYP aged 7-17 years, based on treatment outcomes assessed 
using validated measures relating to anxiety symptoms, including remission 
rates. 
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Following from this overall aim, the main objectives were as follows: 
1) To compare anxiety-related outcomes associated with treatment of four 
anxiety disorders using CC and disorder-specific cognitive behavioural 
interventions. Outcomes considered were remission rates and specific 
validated anxiety measures. 
2) To consider the quality of studies included, to allow for exploration of 
any differences in overall quality of the evidence for disorder specific 
CBT interventions versus CC. 
Methods 
Search strategy 
Searches were conducted by the primary author on 24th April 2015 using the 
research databases Science Direct and APA Psychnet (with each database 
accessing around 2500 peer-reviewed journals), to identify primary research 
articles describing the treatment, using individual psychological therapy, of 
GAD, SAD, SA and SP in children aged 7 – 17 years. The search was 
conducted according to the PRISMA guidelines for conducting systematic 
literature reviews (Moher, Liberati, Tetzlaff, & Altman, 2009). Initially, search 
criteria were entered into the two chosen databases based on the inclusion 
and exclusion criteria presented in Table 1. The reference lists of recent 
review articles were also checked for further relevant articles. The review 
articles used were Reynolds et al. (2012), Davis, May, and Whiting (2011), 
Ishikawa, Okajima, Matsuoka, and Sakano (2007), and Cartwright‐Hatton, 
Roberts, Chitsabesan, Fothergill, and Harrington (2004). The resulting articles 
were combined in a single list and duplicates were removed (see Figure 1).  
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Search criteria 
Inclusion and exclusion criteria used can be found in Table 1. Where the 
afore-mentioned disorders were included together with other disorders, such 
as obsessive-compulsive disorder, and results were not presented separately 
for the disorders of interest, these articles were excluded. In some of the 
earliest studies of CC (Kendall, 1994; Kendall et al, 1997), diagnoses were 
based on DSM-III criteria. These studies included CYP with diagnoses of 
‘overanxious disorder’, ‘avoidant disorder’ and SA. Kendall et al (1997) 
highlighted, however, that in the DSM-IV overanxious disorder was subsumed 
under the diagnosis of GAD, and avoidant disorder under the diagnosis of 
SAD, with the characteristics of identified cases unchanged by the change in 
terminology. Therefore, these studies were included and interpreted according 
to DSM-IV diagnostic categories.  
Table 1. Search criteria >> Table 1 here 
Data extraction 
Data extraction was conducted using a standardised form. The primary author 
performed all data extraction and the resulting summary forms were checked 
by the second author. Discrepancies in judgement were resolved by 
consensus.  
>> Figure 1 here  
Figure 1. PRISMA flow diagram showing study selection and inclusion 
Quality assessment 
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Articles were assessed for quality using the Cochrane Collaboration’s tool for 
assessing risk of bias, recently updated by Higgins et al. (2011). This tool 
allows the researcher to assess randomised-controlled trials for risk of bias 
based on six different domains of possible bias, including selection bias 
(random sequence generation and allocation concealment), performance bias 
(blinding of participants and personnel), detection bias (blinding of outcome 
assessment), attrition bias (incomplete outcome data), reporting bias 
(selective reporting) and ‘other’ bias. The tool was used to guide the 
consideration of potential sources of bias affecting the studies included in the 
present review, and for a comparison between CC and disorder-specific 
treatment studies to be made, although no studies were removed from the 
review based on the identification of possible bias.  
Data analysis 
In order to explore whether there were any differences between disorder-
specific cognitive-behavioural interventions and the disorder-generic CC 
programme for treatment of SAD, GAD, SA, or SP, in CYP aged 7-17 years, 
the outcomes assessed were remission rates (i.e., the number of cases who 
were diagnosis-free at end of treatment), and anxiety symptom severity, if 
assessed using a validated measure. The analysis strategy was a narrative 
review, which included assessment of study quality as well as the outcomes 
noted above.  Assessment of study quality was an important aspect of the 
review, as it allowed for study outcomes to be assessed in the context of 
aspects of their design, methodology and reporting. A meta-analysis was not 
conducted because of the very small number of disorder-specific intervention 
studies available; narrative review was considered to be a more appropriate 
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and meaningful way of synthesising the information to address the review 
question. 
 
Results 
Twenty-four published articles were included in the review. All were 
randomised-controlled trials. Seventeen articles reported outcomes for only 
six original samples – six from the CAMS trial (original study by Walkup et al., 
2008), two from an original study by Kendall et al. (2008), two from Kendall 
(1994), two from Barrett, Dadds, and Rapee (1996), three from Kendall et al. 
(1997), and two from Ollendick et al. (2009), and so these are considered as 
only six single sets of data. This left 13 datasets, or ‘studies’, for inclusion. 
One study compared a disorder-specific treatment approach with CC in 
treatment of SA (Schneider et al, 2013) and was therefore included in both the 
‘CC’ and ‘disorder-specific’ categories. Overall, there were 10 datasets, 
comprising 20 individual articles with 1076 participants in total describing the 
use of CC, and four datasets, comprising five articles and a total of 393 
participants that described a disorder-specific approach. Of the four datasets 
relating to a disorder-specific approach, two described the treatment of SPs, 
one described the treatment of SA, and one described the treatment of SAD. 
No studies relating to treatment of GAD met the inclusion criteria. The studies 
were undertaken in North America, Sweden and Switzerland. Different studies 
assessed diagnostic status in different ways, which limits direct comparisons 
and also precluded a meta-analysis. Table 2 provides a summary of the 
datasets included. 
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Table 2. Characteristics of individual studies included in the review 
>>  Table 2 here 
 
Quality assessment 
An assessment of quality, based on the Cochrane risk of bias assessment 
tool, suggested that there was in some cases an unclear or possibly 
increased risk of bias for many of the studies included. The evidence used to 
assess the risk of bias in each of the six areas is outlined in Supplementary 
Information. Comparison of CC and disorder-specific intervention studies 
suggested that study quality has generally improved over time, with more 
recent studies addressing most of the possible sources of bias considered 
while earlier studies, such as the first studies of CC, had unclear or increased 
risk of bias due to, for example, lack of reporting around the randomisation 
strategy used, lack of blinding or independent raters in the assessment of 
outcome, and unclear methods for monitoring treatment integrity. In addition, 
there was a general move away from using a non-active, waiting-list control, 
to comparison with active treatments in more recent studies. Despite this, the 
small number of studies of disorder-specific CBT interventions meant that 
despite a generally low risk of bias among them, the available evidence for 
disorder-specific CBT remains extremely limited compared to that for CC. 
 
CBT delivery 
In the 10 studies describing the implementation of CC, treatment ranged 
between 12 and 20 approximately weekly sessions of 50 to 80 minutes. All 
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reported following the CC (or Coping Koala) manual, with at least some 
monitoring of treatment integrity, excepting Walkup et al. (2008). Some 
studies specifically reported modification of an existing manual to make it 
more suitable for adolescents (Siqueland et al., 2005; Walkup et al., 2008), for 
example by including visualisation techniques in addition to breathing and 
progressive muscle relaxation exercises, and increased use of cognitive 
restructuring and socratic questioning (Siqueland et al., 2005). 
In the 4 disorder-specific treatment studies, length of intervention ranged 
between a single session of up to three hours (Öst et al., 2001; Ollendick et 
al., 2010) and 12-16 sessions of 50-60 minutes each approximately once per 
week (Herbert et al, 2009; Schneider et al, 2013). All disorder-specific 
interventions were based on an existing manual or published treatment 
protocol, and treatment integrity was explicitly attended to in all studies 
excepting Öst et al. (2001).  
Most studies attended to treatment integrity by assessing CBT delivery 
against pre-defined standards. In addition, many of the studies also provided 
details of therapist training, supervision and competence, which may be 
relevant to outcome. These are briefly summarised in the Supplementary 
Information. There was an increase in reporting of supervision and training 
practice over time. In addition, it is worth noting that the earliest trials of CC 
were conducted in university, rather than community, clinics. However, overall 
there were no major differences in therapist professional status, experience 
and training, or supervision, between CC and disorder-specific studies. 
Diagnostic status after treatment  
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Across studies of CC, the percentage of individuals classified as no longer 
meeting criteria for their primary diagnosis at post-treatment was between 
53% and 87%, across all studies where these data were available (see Table 
2). In the Walkup et al (2008) study, data were only available for 12-week 
follow-up, and for all disorders rather than the primary diagnosis only, and 
suggested a slightly poorer outcome (46.2%). Where long-term follow-up data 
were available in addition to post-treatment data, these suggested slight 
increases in remission rates of primary diagnosis after the CC intervention 
(e.g., Flannery-Schroeder & Kendall, 2000; Barrett et al., 1996, 2001, 
Siqueland et al., 2005). In the only study to report a decrease in the 
percentage of the sample who were diagnosis-free after treatment with CC, 
this decrease occurred between 4 weeks and one year post-treatment, and no 
diagnostic data were available immediately post-treatment (Schneider et al., 
2013).  
Of the 10 studies of CC, 4 compared treatment with CC to a wait-list control 
(Kendall, 1994; Kendall et al., 1997; Barrett, Dadds & Rapee, 1996; Flannery-
Schroeder & Kendall, 2000). In each of these studies, CC was found to be 
significantly more effective, in terms of the percentage of the sample who 
were considered diagnosis-free at the end of treatment, compared to no 
treatment. In studies that included an active control, the outcomes were more 
variable. When compared with a disorder-specific CBT intervention, there 
were no significant differences in terms of the percentage of the sample free 
of their primary SA disorder diagnosis at either 4-weeks or 1-year post-
treatment (Schneider et al,. 2013). Three studies included a comparison 
group who received CC plus a family-based intervention, one compared group 
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versus individual CC, one used a non-directive ‘child centred therapy’ and one 
compared CC with ‘usual care’. Most studies reported no significant 
differences in outcomes for CC versus the active control based on diagnostic 
status (Kendall et al., 2008; Siqueland et al., 2005; Flannery-Schroeder & 
Kendall, 2000; Silk et al., 2013, Southam-Gerow et al., 2010), although one 
study reported CC + family-based intervention outperformed CC alone 
(Barrett, Dadds & Rapee, 1996). 
Some studies were able to compare the effectiveness of CC across different 
disorders within their samples. No significant differences in primary outcomes 
across different primary diagnoses were reported by Barrett, Dadds and 
Rapee (1996) or Kendall et al. (1997). However, both Kerns et al. (2013) and 
Ginsburg et al. (2011; CAMS trial) reported significantly poorer remission 
rates for children with SAD compared to GAD and SA at 7.4 year and 12-
week follow-up, respectively. However, Ginsburg et al.’s study analysis 
included participants who received CBT+sertraline, sertraline only, and 
placebo-only, and so individual outcomes for CC alone could not be 
assessed. 
Across studies of disorder-specific interventions there was also variability in 
the percentage of individuals who no longer met criteria for their primary 
anxiety disorder, or were considered ‘clinically improved’ (see Table 2). There 
were differences between studies in the way that diagnostic outcomes (e.g. 
rates of remission) were assessed. Follow-up periods varied between 6 
months and 1 year. In three cases the rates of remission or clinically 
significant improvement were stable from post-treatment to follow-up (Öst et 
al., 2001; Ollendick et al., 2009; Schneider et al., 2013), and in Herbert et al.’s 
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(2009) study the percentage of ‘remitted’ patients who received the individual 
disorder-specific treatment dropped between post-treatment and 6-month 
follow up, though the authors did not state whether this represented a 
significant decrease. 
Measures of post-treatment severity 
The studies utilised a number of different measures of anxiety symptom 
severity including self-report, parent and teacher report, and clinician/ 
assessor ratings (see Supplementary Information). The findings were mixed, 
demonstrating in some cases advantages of both CC (e.g., Kendall, 1994; 
Kendall & Southam-Gerow, 1996; Barrett, Dadds & Rapee, 1996; Barrett et 
al., 2001; Kendall et al., 1997; Kendall et al., 2004; Kerns et al., 2013; 
Flannery-Schroeder & Kendall, 2000; Kendall et al., 2008; Suveg et al., 2009; 
Walkup et al., 2008; Ginsburg et al., 2011; Caporino et al., 2013; Piacentini et 
al., 2014; Compton  et al., 2014; Beidas et al., 2014) and disorder-specific 
interventions (Öst et al., 2001; Ollendick et al., 2009, 2010), for some 
measures of anxiety symptom severity, particularly over waiting-list control 
conditions, yet in many cases did not demonstrate advantages of CC or 
Disorder-Specific treatments over other interventions (Kendall & Southam-
Gerow, 1996; Barrett, Dadds & Rapee, 1996; Kendall et al., 1997; Kendall et 
al 2004; Kerns et al., 2013; Southam-Gerow et al., 2010; Barrett et al., 2001; 
Flannery-Schroeder & Kendall, 2000; Siqueland, Rynn & Diamond, 2005; 
Kendall et al, 2008; Suveg et al., 2009; Öst et al., 2001; Herbert et al., 2009; 
Ollendick et al., 2009, 2010; Silk et al., 2013) on specific measures of anxiety 
symptom severity. In the only study assessing outcomes for both CC and a 
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disorder-specific intervention for the treatment of SA disorder, little difference 
in outcomes was demonstrated (Schneider et al., 2013).  
 
Discussion 
The present review addressed the following research question: are disorder-
specific cognitive behavioural interventions, as favoured in the treatment of 
anxiety disorders in adults, more effective compared to the disorder-generic 
CC treatment approach for the treatment of SAD, GAD, SA, or SPs in CYP 
aged 7 to 17? The review produced limited evidence that disorder-specific 
approaches produce better outcomes compared to CC, currently 
recommended in England for the treatment of these anxiety disorder 
presentations. This held true for both diagnostic outcome and assessments of 
anxiety severity post-treatment. 
Our finding contrasts with that of a similar review conducted by Reynolds, 
Wilson, Austin and Hooper (2012), who reported that larger effect sizes were 
achieved for disorder-specific compared to disorder-generic treatment 
approaches. However, the present review differed from that of Reynolds et al. 
(2012) in a number of ways. First, as mentioned above, Reynolds et al. 
compared a number of different disorder-generic treatment approaches with 
disorder-specific interventions, while the present review included only 
disorder-generic studies that used CC. Second, Reynolds et al. included 
studies that employed a range of interventions, including CBT, Narrative 
Therapy and Eye Movement Desensitization and Reprocessing, whereas the 
present review included studies of CBT only. Third, Reynolds et al. included a 
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broader range of anxiety disorder presentations than the present study, for 
example OCD and panic disorder. Fourth, the age-range of participants 
included in Reynolds et al.’s review was wider than in the present study. 
Finally, the review conducted by Reynolds and colleagues included studies of 
group and individual interventions, whereas group interventions were not 
considered here. 
In summary, the present review differed from that of Reynolds and colleagues 
in a number of ways, and is therefore able to provide a more detailed and 
flexible comparison of disorder-specific CBT with CC for disorders which CC 
has been recommended as a treatment of choice for CYP presenting in 
CAMHS services in England. For these disorders, there does not seem to be 
a clear overall advantage of disorder-specific CBT interventions over the 
currently recommended CC.  
However, the picture is less clear when each anxiety disorder presentation is 
considered in turn. Although one previous study (Kerns et al., 2013) reported 
poorer outcomes after treatment with CC for children with SAD compared to 
GAD or SA, in Herbert et al.’s (2009) study the outcomes reported for an 
alternative disorder-specific treatment of SAD were not particularly striking, 
and did not provide strong evidence that a disorder-specific intervention is 
more efficacious than a disorder-generic approach. Similarly, in the only study 
reporting outcomes of a disorder-specific CBT intervention for SA (Schneider 
et al., 2013), which included a direct comparison with CC, no clear 
advantages of either treatment were found for remission rates or validated 
measures of anxiety-symptom severity at post-treatment or follow-up at 1-
month or 12-months. The evidence for effectiveness of CC compared to 
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disorder-specific approaches in the treatment of GAD cannot be commented 
on, since no disorder-specific treatment of GAD met inclusion criteria. 
However, the evidence for the effectiveness of CC in treatment of SP is far 
less compelling than that for the other disorders included in this review. Just 
11 participants with a primary diagnosis of SP made up the total 1076 
participants contributed by studies of CC. These 11 participants came from a 
single study – the only study to have included participants with a diagnosis of 
SP in an RCT involving CC (Southam-Gerow et al., 2010). In this study there 
were 48 participants in total. Twenty-four were allocated to receive CC, and 
only 18 completed post-treatment assessments. The exact number with a SP 
who entered the CC intervention arm was not reported, but it is anticipated 
that not all 11 would have received CC. Therefore, given the far greater 
sample sizes of the two studies exploring effectiveness of a disorder-specific 
treatment for SP (combined N = 256), it is not clear that the best available 
evidence supports the use of CC for SP. 
Quality of the evidence and strengths and limitations of the review 
The strengths of the present review include the consideration of a variety of 
outcomes including remission rates and anxiety symptom severity, the 
consideration of validated measures of outcome only, and the use of a 
standardised quality assessment tool. The systematic narrative approach 
allowed for flexible comparisons to be made for studies that used a wide 
variety of measures, designs, implementation of interventions and follow-up 
periods. The approach also allowed for comparisons to be made where the 
existing literature was sparse – i.e., for disorder-specific approaches. 
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However, a number of limitations should also be addressed. The present 
review included only studies involving individual CBT implemented using 
either CC or a disorder-specific cognitive-behavioural protocol. This decision 
was made on the basis of the research question posed, and facilitated direct 
comparison of disorder-specific treatments with CC, which was originally 
devised as an individual intervention. The present review did not aim to 
explore the effectiveness of different variations of CC, such as augmentation 
with a family-based approach or implementation via a group. Inclusion of a 
variety of formats such as group interventions was beyond the scope of the 
review, although where included as an additional treatment arm alongside an 
individual intervention, outcomes were compared. However, the exclusion of 
group-only studies, and those implementing behavioural interventions only, 
meant that a number of disorder-specific studies could not be considered 
here. For example, Spence, Donovan and Brechman-Toussaint (2000) 
reported very positive outcomes for group-based CBT for SAD in 7-14 year-
olds, Beidel, Turner and Morris (2000) reported positive outcomes for a 
behavioural treatment of SAD in 8-12 year-olds, and Clementi and Alfano 
(2014) reported positive outcomes in a small sample of 7-12 year-olds for a 
behavioural treatment of GAD. The ability to include a greater number of 
studies that explored different disorder-specific treatment approaches in the 
review would have been useful in that it would increase the amount of data on 
which conclusions could be drawn, and would also have allowed for the 
consideration of disorder-general versus specific treatments for GAD. In 
addition, comparing different disorder-specific treatment approaches could 
have allowed for cross-comparisons between different approaches for a single 
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disorder to be made. In addition, a number of trials were rejected based to 
their inclusion of CYP outside the 7-17 year age bracket. Although this could 
have affected the findings, it was felt that the imposition of such an age 
bracket was important to ensure that a fair comparison was made for CC, 
which was developed for this age-group only. Thus, the inclusion of studies of 
CC that reported outcomes for children outside of this bracket may not have 
provided a fair representation of the effectiveness of CC, and the inclusion of 
disorder-specific studies reporting outcomes for children not aged 7-17 would 
have been an inappropriate comparison for CC studies. 
Other factors that could affect the conclusions drawn include the country of 
origin (no study included participants from England or the United Kingdom, for 
example), the different outcome measures utilised, variations in analysis 
strategy used, the lack of analysis-by-disorder for CC in many of the studies, 
and the paucity of studies describing implementation of disorder-specific 
approaches. This final limitation could perhaps be viewed as evidence that 
disorder-generic approaches are simply most suited to the treatment of 
childhood anxiety, for example due to the high degree of comorbidity between 
anxiety disorders in this population. Another possibility is that the minimal 
differences found between different approaches in terms of anxiety-related 
outcomes is due to flexibility in the implementation of different interventions. It 
is possible that clinicians delivering disorder-generic treatment approaches 
such as CC will naturally make small adjustments according to the child’s 
presentation, meaning that in practice there is little difference between 
disorder-specific and disorder-generic approaches. Such flexibility could mean 
that a disorder-generic treatment such as CC is a more pragmatic intervention 
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because it would likely require less staff training and therefore allow a greater 
throughput of patients than employment of a number of separate disorder-
specific treatments by a service. This is particularly relevant given the finding 
that no treatment approach appeared to ‘stand out’ against any other in terms 
of outcomes. 
Policy and practice implications 
The present review was motivated by the observation of a difference in 
approach to the treatment of anxiety disorders in children and adults. While 
the adult literature generally supports disorder-specific approaches, disorder-
generic treatments are often utilised in treatment of child anxiety disorders. 
This is reflected in the CYP IAPT National Curriculum (2013), which outlines 
recommended treatments for anxiety disorders in CYP and suggests that CC 
is used to inform the treatment of GAD, SA disorder, SAD and SP, whilst 
acknowledging the limited evidence base for treatment of these disorders in 
CYP. 
As noted above, for the treatment of SA and SAD, the evidence does not 
appear to favour either a disorder-specific or a disorder-generic treatment 
approach. Nor does it appear to favour one mode of delivery of CC (i.e., 
individual versus group, CC augmented with specific family interventions) or 
even, in many cases, CC rather than alternative interventions such as ‘usual 
care’ or ‘non-directive supportive psychotherapy’. Therefore, in the absence of 
a clear alternative to CC, no changes are recommended for the guidelines on 
treatment of these disorders, nor for general practice, although 
recommendations for future research are discussed below. For the treatment 
of SPs, however, it is suggested that the evidence for the use of CC to inform 
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intervention is not sufficiently compelling at present. Therefore, we suggest 
that alternative treatment approaches be considered for the CYP IAPT 
National Curriculum, and that clinicians consider the weight of the evidence 
for different approaches to inform their practice. A detailed review of 
alternatives for the treatment of SPs was beyond the scope of this project, 
although it is suggested that Öst and colleagues’ One Session Treatment for 
SPs is one possible alternative (Öst et al., 2001). Indeed, a clear benefit of 
such a package for treatment of SPs is the relatively small amount of time 
required for the treatment – a single session of up to three hours - compared 
to 16 hours of CC, if delivered according to the manual: a large potential 
saving in clinician hours. 
Recommendations for future research 
A key recommendation is that further studies should compare outcomes for 
the disorder-generic treatment, CC, with disorder-specific approaches. In 
addition, it is recommended that a review be conducted of the current 
evidence base for different disorder-specific approaches to the treatment of 
SPs in CYP, given the finding that the evidence base for use of CC in the 
treatment of SPs appears extremely limited. It is also recommended that 
future studies consider disorder-specific and disorder-generic approaches in 
terms of their ability to provide cost-efficiency as well as positive outcomes, by 
assessing factors such as treatment duration and use of additional services, 
and by implementing the treatment approaches in community settings rather 
than university clinics, as described in the study by Southam-Gerow and 
colleagues (2010) included in this review. 
Conclusions 
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The disorder-generic treatment for childhood anxiety disorders, CC, appears 
to be equally effective compared to disorder-specific treatments for SAD and 
SA. Conclusions about disorder-specific treatments for GAD could not be 
drawn. However, for SPs the current evidence appears to favour disorder-
specific treatments over CC. Study quality appears to have improved over 
time, although future studies should begin to utilise direct comparisons of CC 
with alternative disorder-specific treatments and assess effectiveness for 
treatments in terms of cost and time, based on community, rather than 
university clinic settings. A useful direction for future reviews would be to 
consider evidence for disorder specific versus generic approaches for 
particular disorders.  
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